ASLAN Pharmaceuticals (ASLN)
(Delayed Data from NSDQ)
$2.47 USD
+0.18 (7.86%)
Updated Jul 11, 2024 03:52 PM ET
After-Market: $2.46 -0.01 (-0.40%) 5:24 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ASLN 2.47 +0.18(7.86%)
Will ASLN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ASLN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ASLN
All You Need to Know About ASLAN Pharmaceuticals (ASLN) Rating Upgrade to Buy
Here's Why ASLAN Pharmaceuticals (ASLN) Could be Great Choice for a Bottom Fisher
ASLN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?
Is Aclaris Therapeutics (ACRS) Stock Outpacing Its Medical Peers This Year?
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
Other News for ASLN
Catalyst Watch: Tesla deliveries, Constellation Brands earnings, and the June Jobs Report
12 Health Care Stocks Moving In Friday's Pre-Market Session
Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday